(Q34011516)

30 July 2017

1 reference

title

Effects of growth hormone and prolactin on hematopoiesis (English)

1 reference

30 July 2017

0 references

1

Welniak LA

0 references

William J. Murphy

7

object named as

Murphy WJ

0 references

Francis W. Ruscetti

6

object named as

Ruscetti FW

1 reference

30 July 2017

Tian ZG

2

1 reference

30 July 2017

Sun R

3

1 reference

30 July 2017

Keller JR

4

1 reference

30 July 2017

Richards S

5

1 reference

30 July 2017

language of work or name

1 reference

1 August 2000

1 reference

30 July 2017

1 reference

30 July 2017

volume

38

1 reference

30 July 2017

issue

5-6

1 reference

30 July 2017

page(s)

435-445

1 reference

Prolactin and growth hormone in the regulation of the immune system

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F10428190009059263

Hypophysectomized rats depend on residual prolactin for survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009059263

Defective mammopoiesis, but normal hematopoiesis, in mice with a targeted disruption of the prolactin gene

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009059263

Pituitary dependence of bone marrow function

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009059263

The influence of growth hormone substitution therapy on erythroid and myeloid progenitor cells and on peripheral blood cells in adult patients with growth hormone deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009059263

Prolactin exerts hematopoietic growth-promoting effects in vivo and partially counteracts myelosuppression by azidothymidine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009059263

Differential effects of growth hormone and prolactin on murine T cell development and function

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009059263

Activation of the prolactin receptor but not the growth hormone receptor is important for induction of mammary tumors in transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009059263

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009059263

Risk of leukemia in children treated with human growth hormone: review and reanalysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009059263

Mortality, neoplasia, and Creutzfeldt-Jakob disease in patients treated with human pituitary growth hormone in the United Kingdom

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009059263

Growth hormone, growth factors and hematopoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009059263

Enhancement of human granulopoiesis in vitro by biosynthetic insulin-like growth factor I/somatomedin C and human growth hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009059263

A reappraisal of the role of insulin-like growth factor I in the regulation of human hematopoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009059263

THE PHENOTYPE AND RECONSTITUTION OF IMMUNOREGULATORY T CELL SUBSETS AFTER T CELL-DEPLETED ALLOGENEIC AND AUTOLOGOUS BONE MARROW TRANSPLANTATION

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009059263

10.3109/10428190009059263

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference